Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Erector spinae block for pain control after kidney stone surgery

Official title: Erector Spinae Plane Block Versus Control for Pain Control Following Percutaneous Nephrolithotomy: A Randomized, Double-Blind, Placebo Controlled Study

Run by University of Tennessee Medical Center · NCT05024344 · Data updated 2026-11-12

This study tests if a special pain relief technique called the erector spinae block can help adults have less pain and use fewer opioids after kidney stone surgery.

More Percutaneous Nephrolithotomy trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment128 (estimated)
SponsorUniversity of Tennessee Medical Center
Academic / other
Locations1 site (Knoxville, Tennessee)
StatusRecruiting
StartedAugust 9, 2021
Main results expectedDecember 31, 2027
Study endsJune 30, 2028
Registry record updatedApril 28, 2026
Trial IDNCT05024344 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older scheduled for non-emergent percutaneous nephrolithotomy.

Probably not a fit

Patients with emergent surgery needs, local infections, or significant underlying medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of the erector spinae (ESP) block in reducing opioid consumption and pain levels following elective percutaneous nephrolithotomy. A total of 128 adult participants will be randomly assigned to receive either the ESP block or a saline control during their procedure. The study will assess outcomes such as morphine milligram equivalent (MME) consumption and pain levels at various postoperative intervals using validated questionnaires and scales. Data will be collected and analyzed to determine the impact of the ESP block on recovery quality and pain management.

Why it matters

Potential benefit: If successful, this approach could lead to reduced opioid use and improved pain management for patients undergoing kidney stone surgery.

How similar studies have gone: Other studies have shown promising results with the use of erector spinae blocks for pain management, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM.
* Female participants of childbearing potential will be required to provide a negative pregnancy test.
* Ability to understand and teach back consent for the procedure.
* Willingness to sign consent for procedure.
* English speaking.

Exclusion Criteria:

* Emergent surgery status.
* Local infection
* Allergy to local anesthetics.
* Recreational drug use.
* Inability to provide informed consent.
* Pregnancy or breastfeeding.
* History of Guillain-Barre' Syndrome.
* Underlying medical conditions that would post a significant risk to the patient.
* Opioid use \>90 days in the year leading up to surgery.

Where it's running

  • University of Tennessee Medical Center
    Knoxville, Tennessee, United States
    Recruiting

Study contacts

  • Principal investigator: Jason Buehler, MD — University of Tennessee Medical Center
  • Study coordinator: Jason Buehler, MD
  • Email: jbuehler@utmck.edu
  • Phone: 865-305-9220

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.